CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company
Cabaletta Bio, Inc.
Sign in to watch- Ticker
- CABA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 759-3100
- Business address
- 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-19 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-05-19 | Simon Mark Director | Returned to the company · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2025-05-19 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-05-19 | Simon Mark Director | Returned to the company · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2025-05-19 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Returned to the company · Stock Option (Right to Buy) | −66,667 | 0 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Grant or award · Stock Option (Right to Buy) | +66,667 | 66,667 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Returned to the company · Stock Option (Right to Buy) | −29,908 | 0 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Grant or award · Stock Option (Right to Buy) | +29,908 | 29,908 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Returned to the company · Stock Option (Right to Buy) | −160,000 | 0 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Returned to the company · Stock Option (Right to Buy) | −176,000 | 0 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Grant or award · Stock Option (Right to Buy) | +176,000 | 176,000 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Returned to the company · Stock Option (Right to Buy) | −130,000 | 0 | ||
| 2025-05-19 | Binder Gwendolyn President, Science & Tech. | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2025-05-19 | Das Arun Chief Business Officer | Returned to the company · Stock Option (Right to Buy) | −18,416 | 0 | ||
| 2025-05-19 | Das Arun Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +18,416 | 18,416 | ||
| 2025-05-19 | Das Arun Chief Business Officer | Returned to the company · Stock Option (Right to Buy) | −35,000 | 0 |
Page 5 of 13 · 256 trades